UAE Cell Therapy Raw Materials Market Size & Outlook
Related Markets
UAE cell therapy raw materials market highlights
- The UAE cell therapy raw materials market generated a revenue of USD 10.4 million in 2025 and is expected to reach USD 43.6 million by 2033.
- The UAE market is expected to grow at a CAGR of 20% from 2026 to 2033.
- In terms of segment, cell culture supplements was the largest revenue generating products in 2025.
- Media is the most lucrative products segment registering the fastest growth during the forecast period.
Cell therapy raw materials market data book summary
| Market revenue in 2025 | USD 10.4 million |
| Market revenue in 2033 | USD 43.6 million |
| Growth rate | 20% (CAGR from 2026 to 2033) |
| Largest segment | Cell culture supplements |
| Fastest growing segment | Media |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Media, Sera, Cell Culture Supplements, Antibodies, Reagents & Buffers |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Danaher Corp, Sartorius AG, Stemcell Holdings Inc Ordinary Shares, Grifols SA Ordinary Shares - Class A, Charles River Laboratories International Inc, Actylis, ACROBiosystems, RoosterBio, PromoCell GmbH |
Other key industry trends
- In terms of revenue, UAE accounted for 0.2% of the global cell therapy raw materials market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Middle East & Africa, Saudi Arabia cell therapy raw materials market is projected to lead the regional market in terms of revenue in 2033.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 43.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Therapy Raw Materials Market Scope
Cell Therapy Raw Materials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| RoosterBio | View profile | 1-10 | Frederick, Maryland, United States, North America | http://roosterbio.com |
| ACROBiosystems | View profile | 251-500 | Newark, Delaware, United States, North America | https://www.acrobiosystems.com/ |
| Actylis | View profile | 501-1000 | Port Washington, New York, United States, North America | https://actylis.com |
| PromoCell GmbH | View profile | 51-100 | Heidelberg, Baden-Wurttemberg, Germany, Europe | http://www.promocell.com/ |
| Grifols SA Ordinary Shares - Class A | View profile | 23737 | Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, Spain, 08174 | https://www.grifols.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Stemcell Holdings Inc Ordinary Shares | View profile | - | 1185 Avenue of the Americas, 3rd Floor, New York, NY, United States, 10036 | https://www.stemcell-holdings.com |
| Sartorius AG | View profile | 14338 | Otto-Brenner-Strasse 20, Gottingen, NI, Germany, 37079 | https://www.sartorius.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
UAE cell therapy raw materials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell therapy raw materials market will help companies and investors design strategic landscapes.
Cell culture supplements was the largest segment with a revenue share of 29.81% in 2025. Horizon Databook has segmented the UAE cell therapy raw materials market based on media, sera, cell culture supplements, antibodies, reagents & buffers covering the revenue growth of each sub-segment from 2021 to 2033.
The cell therapy raw materials market in the UAE is experiencing strong growth, fueled by advancements in regenerative medicine and personalized treatments. The increasing prevalence of chronic diseases like cancer and autoimmune disorders is driving the demand for cell therapies, which require key raw materials such as cell culture media, growth factors, and cytokines.
The UAE’s robust healthcare infrastructure, coupled with significant investments in biotechnology, is boosting the market. Additionally, government initiatives to promote research and innovation in the biotech sector, along with partnerships between local and international companies, are further accelerating the growth of the cell therapy raw materials market in the region.
Reasons to subscribe to UAE cell therapy raw materials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UAE cell therapy raw materials market databook
-
Our clientele includes a mix of cell therapy raw materials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE cell therapy raw materials market , including forecasts for subscribers. This country databook contains high-level insights into UAE cell therapy raw materials market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
UAE cell therapy raw materials market size, by products, 2021-2033 (US$M)
UAE Cell Therapy Raw Materials Market Outlook Share, 2025 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
